PMC:7796041 / 14510-15965
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"396","span":{"begin":151,"end":159},"obj":"Species"},{"id":"397","span":{"begin":239,"end":247},"obj":"Species"},{"id":"398","span":{"begin":433,"end":440},"obj":"Species"},{"id":"399","span":{"begin":572,"end":580},"obj":"Species"},{"id":"400","span":{"begin":751,"end":758},"obj":"Species"},{"id":"401","span":{"begin":863,"end":871},"obj":"Species"},{"id":"402","span":{"begin":1040,"end":1048},"obj":"Species"},{"id":"403","span":{"begin":1123,"end":1131},"obj":"Species"},{"id":"404","span":{"begin":1140,"end":1148},"obj":"Species"},{"id":"405","span":{"begin":1274,"end":1282},"obj":"Species"},{"id":"406","span":{"begin":1352,"end":1360},"obj":"Species"},{"id":"407","span":{"begin":970,"end":980},"obj":"Chemical"},{"id":"408","span":{"begin":15,"end":25},"obj":"Disease"},{"id":"409","span":{"begin":63,"end":71},"obj":"Disease"},{"id":"410","span":{"begin":73,"end":75},"obj":"Disease"},{"id":"411","span":{"begin":104,"end":114},"obj":"Disease"},{"id":"412","span":{"begin":181,"end":191},"obj":"Disease"},{"id":"413","span":{"begin":269,"end":279},"obj":"Disease"},{"id":"414","span":{"begin":328,"end":330},"obj":"Disease"},{"id":"415","span":{"begin":368,"end":378},"obj":"Disease"},{"id":"416","span":{"begin":380,"end":391},"obj":"Disease"},{"id":"417","span":{"begin":488,"end":499},"obj":"Disease"},{"id":"418","span":{"begin":604,"end":627},"obj":"Disease"},{"id":"419","span":{"begin":629,"end":631},"obj":"Disease"},{"id":"420","span":{"begin":678,"end":680},"obj":"Disease"},{"id":"421","span":{"begin":710,"end":734},"obj":"Disease"},{"id":"422","span":{"begin":764,"end":786},"obj":"Disease"},{"id":"423","span":{"begin":829,"end":852},"obj":"Disease"},{"id":"424","span":{"begin":966,"end":968},"obj":"Disease"},{"id":"425","span":{"begin":1154,"end":1165},"obj":"Disease"},{"id":"426","span":{"begin":1288,"end":1290},"obj":"Disease"},{"id":"427","span":{"begin":1369,"end":1380},"obj":"Disease"},{"id":"428","span":{"begin":1415,"end":1432},"obj":"Disease"},{"id":"429","span":{"begin":1436,"end":1454},"obj":"Disease"}],"attributes":[{"id":"A396","pred":"tao:has_database_id","subj":"396","obj":"Tax:9606"},{"id":"A397","pred":"tao:has_database_id","subj":"397","obj":"Tax:9606"},{"id":"A398","pred":"tao:has_database_id","subj":"398","obj":"Tax:9606"},{"id":"A399","pred":"tao:has_database_id","subj":"399","obj":"Tax:9606"},{"id":"A400","pred":"tao:has_database_id","subj":"400","obj":"Tax:9606"},{"id":"A401","pred":"tao:has_database_id","subj":"401","obj":"Tax:9606"},{"id":"A402","pred":"tao:has_database_id","subj":"402","obj":"Tax:9606"},{"id":"A403","pred":"tao:has_database_id","subj":"403","obj":"Tax:9606"},{"id":"A404","pred":"tao:has_database_id","subj":"404","obj":"Tax:9606"},{"id":"A405","pred":"tao:has_database_id","subj":"405","obj":"Tax:9606"},{"id":"A406","pred":"tao:has_database_id","subj":"406","obj":"Tax:9606"},{"id":"A407","pred":"tao:has_database_id","subj":"407","obj":"MESH:D000638"},{"id":"A408","pred":"tao:has_database_id","subj":"408","obj":"MESH:D001145"},{"id":"A409","pred":"tao:has_database_id","subj":"409","obj":"MESH:C000657245"},{"id":"A410","pred":"tao:has_database_id","subj":"410","obj":"MESH:D001281"},{"id":"A411","pred":"tao:has_database_id","subj":"411","obj":"MESH:D001145"},{"id":"A412","pred":"tao:has_database_id","subj":"412","obj":"MESH:D001145"},{"id":"A413","pred":"tao:has_database_id","subj":"413","obj":"MESH:D001145"},{"id":"A414","pred":"tao:has_database_id","subj":"414","obj":"MESH:D001281"},{"id":"A415","pred":"tao:has_database_id","subj":"415","obj":"MESH:D001145"},{"id":"A416","pred":"tao:has_database_id","subj":"416","obj":"MESH:D001919"},{"id":"A417","pred":"tao:has_database_id","subj":"417","obj":"MESH:D001919"},{"id":"A418","pred":"tao:has_database_id","subj":"418","obj":"MESH:D017180"},{"id":"A419","pred":"tao:has_database_id","subj":"419","obj":"MESH:D017180"},{"id":"A420","pred":"tao:has_database_id","subj":"420","obj":"MESH:D017180"},{"id":"A421","pred":"tao:has_database_id","subj":"421","obj":"MESH:D014693"},{"id":"A422","pred":"tao:has_database_id","subj":"422","obj":"MESH:D002318"},{"id":"A423","pred":"tao:has_database_id","subj":"423","obj":"MESH:D017180"},{"id":"A424","pred":"tao:has_database_id","subj":"424","obj":"MESH:D001281"},{"id":"A425","pred":"tao:has_database_id","subj":"425","obj":"MESH:D001145"},{"id":"A426","pred":"tao:has_database_id","subj":"426","obj":"MESH:D001281"},{"id":"A427","pred":"tao:has_database_id","subj":"427","obj":"MESH:D001145"},{"id":"A428","pred":"tao:has_database_id","subj":"428","obj":"MESH:D020246"},{"id":"A429","pred":"tao:has_database_id","subj":"429","obj":"MESH:D011655"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"With regard to arrhythmia diagnosis during hospitalization for COVID-19, AF was the most common type of arrhythmia recorded (Figure 2A). Similarly, in patients diagnosed with a new arrhythmia type during hospitalization (Figure 2B) and in patients without any previous arrhythmia diagnosis prior to hospitalization (Figure 2C), AF constituted the most common incident arrhythmia. Bradycardia was recorded in four cases, of which one patient already had previously documented asymptomatic bradycardia. No pacemaker implantation was necessary in this subgroup. In addition, patients with frequent PVCs and ventricular tachycardia (VT) constituted relevant subgroups. All recorded VT-episodes were non-sustained. Ventricular fibrillation occurred in one patient with cardiovascular disease who had previously received an ICD due to ventricular tachycardia. In three patients (1.8%) electrical cardioversion was performed for termination of hemodynamically compromising AF. Amiodarone for pharmacological cardioversion was administered in four patients (2.4%), and chronic antiarrhythmic medical therapy was initiated in three patients (1.8%). Patients with arrhythmias more often received therapeutic anticoagulation therapy (Table 1) in accordance with the high proportion of patients with AF in this subgroup. Reasons for therapeutic anticoagulation in patients without arrhythmias were previous or new diagnosis of venous thrombosis or pulmonary embolism."}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T82","span":{"begin":15,"end":25},"obj":"Phenotype"},{"id":"T83","span":{"begin":73,"end":75},"obj":"Phenotype"},{"id":"T84","span":{"begin":104,"end":114},"obj":"Phenotype"},{"id":"T85","span":{"begin":181,"end":191},"obj":"Phenotype"},{"id":"T86","span":{"begin":269,"end":279},"obj":"Phenotype"},{"id":"T87","span":{"begin":328,"end":330},"obj":"Phenotype"},{"id":"T88","span":{"begin":368,"end":378},"obj":"Phenotype"},{"id":"T89","span":{"begin":380,"end":391},"obj":"Phenotype"},{"id":"T90","span":{"begin":488,"end":499},"obj":"Phenotype"},{"id":"T91","span":{"begin":604,"end":627},"obj":"Phenotype"},{"id":"T92","span":{"begin":629,"end":631},"obj":"Phenotype"},{"id":"T93","span":{"begin":678,"end":680},"obj":"Phenotype"},{"id":"T94","span":{"begin":710,"end":734},"obj":"Phenotype"},{"id":"T95","span":{"begin":764,"end":786},"obj":"Phenotype"},{"id":"T96","span":{"begin":829,"end":852},"obj":"Phenotype"},{"id":"T97","span":{"begin":966,"end":968},"obj":"Phenotype"},{"id":"T98","span":{"begin":1154,"end":1165},"obj":"Phenotype"},{"id":"T99","span":{"begin":1288,"end":1290},"obj":"Phenotype"},{"id":"T100","span":{"begin":1369,"end":1380},"obj":"Phenotype"},{"id":"T101","span":{"begin":1415,"end":1432},"obj":"Phenotype"},{"id":"T102","span":{"begin":1436,"end":1454},"obj":"Phenotype"}],"attributes":[{"id":"A82","pred":"hp_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/HP_0011675"},{"id":"A83","pred":"hp_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/HP_0005110"},{"id":"A84","pred":"hp_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/HP_0011675"},{"id":"A85","pred":"hp_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/HP_0011675"},{"id":"A86","pred":"hp_id","subj":"T86","obj":"http://purl.obolibrary.org/obo/HP_0011675"},{"id":"A87","pred":"hp_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/HP_0005110"},{"id":"A88","pred":"hp_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/HP_0011675"},{"id":"A89","pred":"hp_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/HP_0001662"},{"id":"A90","pred":"hp_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/HP_0001662"},{"id":"A91","pred":"hp_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/HP_0004756"},{"id":"A92","pred":"hp_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/HP_0004756"},{"id":"A93","pred":"hp_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/HP_0004756"},{"id":"A94","pred":"hp_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/HP_0001663"},{"id":"A95","pred":"hp_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/HP_0001626"},{"id":"A96","pred":"hp_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/HP_0004756"},{"id":"A97","pred":"hp_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/HP_0005110"},{"id":"A98","pred":"hp_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/HP_0011675"},{"id":"A99","pred":"hp_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/HP_0005110"},{"id":"A100","pred":"hp_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/HP_0011675"},{"id":"A101","pred":"hp_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/HP_0004936"},{"id":"A102","pred":"hp_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/HP_0002204"}],"text":"With regard to arrhythmia diagnosis during hospitalization for COVID-19, AF was the most common type of arrhythmia recorded (Figure 2A). Similarly, in patients diagnosed with a new arrhythmia type during hospitalization (Figure 2B) and in patients without any previous arrhythmia diagnosis prior to hospitalization (Figure 2C), AF constituted the most common incident arrhythmia. Bradycardia was recorded in four cases, of which one patient already had previously documented asymptomatic bradycardia. No pacemaker implantation was necessary in this subgroup. In addition, patients with frequent PVCs and ventricular tachycardia (VT) constituted relevant subgroups. All recorded VT-episodes were non-sustained. Ventricular fibrillation occurred in one patient with cardiovascular disease who had previously received an ICD due to ventricular tachycardia. In three patients (1.8%) electrical cardioversion was performed for termination of hemodynamically compromising AF. Amiodarone for pharmacological cardioversion was administered in four patients (2.4%), and chronic antiarrhythmic medical therapy was initiated in three patients (1.8%). Patients with arrhythmias more often received therapeutic anticoagulation therapy (Table 1) in accordance with the high proportion of patients with AF in this subgroup. Reasons for therapeutic anticoagulation in patients without arrhythmias were previous or new diagnosis of venous thrombosis or pulmonary embolism."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T131","span":{"begin":0,"end":136},"obj":"Sentence"},{"id":"T132","span":{"begin":137,"end":379},"obj":"Sentence"},{"id":"T133","span":{"begin":380,"end":500},"obj":"Sentence"},{"id":"T134","span":{"begin":501,"end":558},"obj":"Sentence"},{"id":"T135","span":{"begin":559,"end":664},"obj":"Sentence"},{"id":"T136","span":{"begin":665,"end":709},"obj":"Sentence"},{"id":"T137","span":{"begin":710,"end":853},"obj":"Sentence"},{"id":"T138","span":{"begin":854,"end":969},"obj":"Sentence"},{"id":"T139","span":{"begin":970,"end":1139},"obj":"Sentence"},{"id":"T140","span":{"begin":1140,"end":1308},"obj":"Sentence"},{"id":"T141","span":{"begin":1309,"end":1455},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"With regard to arrhythmia diagnosis during hospitalization for COVID-19, AF was the most common type of arrhythmia recorded (Figure 2A). Similarly, in patients diagnosed with a new arrhythmia type during hospitalization (Figure 2B) and in patients without any previous arrhythmia diagnosis prior to hospitalization (Figure 2C), AF constituted the most common incident arrhythmia. Bradycardia was recorded in four cases, of which one patient already had previously documented asymptomatic bradycardia. No pacemaker implantation was necessary in this subgroup. In addition, patients with frequent PVCs and ventricular tachycardia (VT) constituted relevant subgroups. All recorded VT-episodes were non-sustained. Ventricular fibrillation occurred in one patient with cardiovascular disease who had previously received an ICD due to ventricular tachycardia. In three patients (1.8%) electrical cardioversion was performed for termination of hemodynamically compromising AF. Amiodarone for pharmacological cardioversion was administered in four patients (2.4%), and chronic antiarrhythmic medical therapy was initiated in three patients (1.8%). Patients with arrhythmias more often received therapeutic anticoagulation therapy (Table 1) in accordance with the high proportion of patients with AF in this subgroup. Reasons for therapeutic anticoagulation in patients without arrhythmias were previous or new diagnosis of venous thrombosis or pulmonary embolism."}